APLLTD — Alembic Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Alembic Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	C2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,991	718	2,850	611	755
Net Total Accounts Receivable
Net Total Receivables	4,945	9,036	3,706	8,362	11,341
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19,577	24,628	26,520	28,608	29,100
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24,398	30,990	36,472	39,473	29,997
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	47,778	59,891	67,090	71,220	61,828
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,896	17,516	12,808	17,165	16,369
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	20,589	27,696	16,420	18,845	18,124
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	27,188	32,194	50,670	52,376	43,705
Total Liabilities & Shareholders' Equity	47,778	59,891	67,090	71,220	61,828
Total Common Shares Outstanding